Zhu, Jingjing
Wilding, John P. H.
Funding for this research was provided by:
Second Affiliated Hospital of Soochow University (SDFEYBS1815)
China Scholarship Council (202006920018)
Government of Jiangsu Province (The Jiangsu Innovation & Career Fund for PhD 2019)
Article History
Accepted: 4 December 2023
First Online: 27 December 2023
Declarations
:
: Conflicts of Interest: Professor Wilding reports grants and personal fees from AstraZeneca; personal fees and consultancy fees paid to his institution from Boehringer Ingelheim; grants; personal fees and consultancy paid to his institution from Novo Nordisk; consultancy fees paid to his institution from Altimmune, Eli Lilly, Menarini, Napp, Pfizer, Rhythm Pharmaceuticals, Saniona, Tern, Shionogi, and Ysopia, outside the submitted work. Dr. Zhu reports no conflict of interest.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki Declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).